Spots Global Cancer Trial Database for acute biphenotypic leukemia

Every month we try and update this database with for acute biphenotypic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting	NCT04128501	Acute Bilineal ... Acute Biphenoty... Acute Myeloid L... Mixed Phenotype... T Acute Lymphob... Therapy-Related...	Azacitidine Venetoclax	18 Years - 75 Years	M.D. Anderson Cancer Center
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies	NCT02529813	Acute Biphenoty... Acute Lymphobla... Blasts 5 Percen... CD19 Positive Minimal Residua... Non-Hodgkin Lym... Small Lymphocyt... Stage III Chron... Stage IV Chroni...	Cyclophosphamid... Fludarabine Pho... Laboratory Biom... Tisagenlecleuce...	1 Year - 80 Years	M.D. Anderson Cancer Center
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes	NCT03399773	Acute Biphenoty... Acute Lymphobla... Chronic Myeloge... Hematopoietic a... Myelodysplastic... Myelodysplastic...	Dilanubicel Cyclophosphamid... Fludarabine Thiotepa Total-Body Irra... Umbilical Cord ... Laboratory Biom... Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Multigated Acqu... Electrocardiogr... Computed Tomogr...	10 Years - 65 Years	Fred Hutchinson Cancer Center
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies	NCT05170828	Acute Leukemia Myelodysplastic... T-lymphoblastic... Acute Lymphocyt... Acute Myeloid L... Acute Biphenoty... Acute Undiffere...	Cyclophosphamid... Fludarabine Total Body Irra... Busulfan Mesna Sirolimus Mycophenolate M... Filgrastim Cyclophosphamid... Bone Marrow Tra...	18 Years - 70 Years	Ossium Health, Inc.
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation	NCT00990249	Leukemia Lymphoma Allogeneic Haem... Acute Lymphobla...	Busulfan Clofarabine Thymoglobulin Stem Cell Trans...	- 65 Years	M.D. Anderson Cancer Center
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children	NCT01858740	Accelerated Pha... Acute Biphenoty... Acute Leukemia ... Acute Undiffere... Adult Acute Lym... Adult Acute Mye... Blast Phase Chr... Childhood Acute... Childhood Acute... Chronic Myeloge... Myelodysplastic... Myelodysplastic... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Adul... Refractory Chil...	Allogeneic Hema... Fludarabine Pho... Laboratory Biom... Methotrexate Peripheral Bloo... T Cell-Depleted... Tacrolimus Thiotepa Total-Body Irra...	- 21 Years	Fred Hutchinson Cancer Center
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies	NCT02529813	Acute Biphenoty... Acute Lymphobla... Blasts 5 Percen... CD19 Positive Minimal Residua... Non-Hodgkin Lym... Small Lymphocyt... Stage III Chron... Stage IV Chroni...	Cyclophosphamid... Fludarabine Pho... Laboratory Biom... Tisagenlecleuce...	1 Year - 80 Years	M.D. Anderson Cancer Center
NK Cells in Cord Blood Transplantation	NCT01619761	Accelerated Pha... Acute Biphenoty... Acute Lymphobla... Acute Myeloid L... Chronic Phase C... DS Stage II Pla... DS Stage III Pl... High Grade B-Ce... ISS Stage II Pl... ISS Stage III P... Myelodysplastic... Recurrent Acute... Recurrent Acute... Recurrent Chron... Recurrent Hodgk... Recurrent Non-H... Recurrent Small... Refractory Acut... Refractory Chro... Refractory Hodg... Refractory Non-... Refractory Smal... Secondary Acute... Therapy-Related... Therapy-Related...	Allogeneic Hema... Cyclophosphamid... Fludarabine Pho... Laboratory Biom... Lenalidomide Melphalan Mycophenolate M... Natural Killer ... Rituximab Tacrolimus Total-Body Irra... Umbilical Cord ...	- 75 Years	M.D. Anderson Cancer Center
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes	NCT02044796	Acute Biphenoty... de Novo Myelody... Previously Trea... Recurrent Adult... Untreated Adult... Secondary Acute...	Cladribine Cytarabine Filgrastim Laboratory Biom... Mitoxantrone Hy...	18 Years -	Fred Hutchinson Cancer Center
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD	NCT02220985	Accelerated Pha... Acute Biphenoty... Acute Leukemia ... Acute Undiffere... Allogeneic Hema... Blast Phase Chr... Blastic Plasmac... Childhood Acute... Childhood Acute... Donor Lymphoblastic L... Myelodysplastic... Myelodysplastic... Myelodysplastic... Recurrent Acute... Recurrent Acute... Recurrent Child... Recurrent Child... Recurrent Chron... Refractory Acut... Refractory Acut... Acute Lymphobla... Acute Myeloid L...	Allogeneic Hema... Cyclophosphamid... Fludarabine Pho... Laboratory Biom... Methotrexate Mycophenolate M... Peripheral Bloo... Peripheral Bloo... Tacrolimus Thiotepa Total-Body Irra...	- 60 Years	Fred Hutchinson Cancer Center
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia	NCT01804101	Acute Biphenoty... Acute Myeloid L... Myelodysplastic... Untreated Adult...	Laboratory Biom... Liposomal Cytar...	18 Years -	Fred Hutchinson Cancer Center
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia	NCT03195010	Acute Biphenoty... Acute Lymphobla... Acute Myeloid L... B-Cell Non-Hodg... Chronic Lymphoc... Chronic Myeloge... Hematologic and... Hematopoietic C... Myelodysplastic... Primary Myelofi... Secondary Myelo... T-Cell Non-Hodg... Thrombocytopeni... Venous Thromboe...	Platelet Transf... Platelet Transf...	18 Years -	Fred Hutchinson Cancer Center
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	NCT02728050	Acute Biphenoty... Acute Myeloid L... de Novo Myelody... Myelodysplastic... Myeloproliferat...	Cladribine Cytarabine Filgrastim Laboratory Biom... Quality-of-Life... Mitoxantrone Sorafenib	18 Years - 60 Years	University of Washington
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation	NCT03683433	Acute Bilineal ... Acute Biphenoty... Chronic Myelomo... IDH2 Gene Mutat... Myelodysplastic... Recurrent Acute... Refractory Acut...	Azacitidine Enasidenib Mesy...	18 Years -	M.D. Anderson Cancer Center
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children	NCT01858740	Accelerated Pha... Acute Biphenoty... Acute Leukemia ... Acute Undiffere... Adult Acute Lym... Adult Acute Mye... Blast Phase Chr... Childhood Acute... Childhood Acute... Chronic Myeloge... Myelodysplastic... Myelodysplastic... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Adul... Refractory Chil...	Allogeneic Hema... Fludarabine Pho... Laboratory Biom... Methotrexate Peripheral Bloo... T Cell-Depleted... Tacrolimus Thiotepa Total-Body Irra...	- 21 Years	Fred Hutchinson Cancer Center
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma	NCT03096782	Accelerated Pha... Acute Biphenoty... Acute Leukemia Acute Lymphobla... Acute Lymphobla... Acute Myeloid L... Acute Myeloid L... Chemotherapy-Re... Chronic Lymphoc... Chronic Myeloge... Chronic Myelomo... Hodgkin Lymphom... Langerhans Cell... Minimal Residua... Myelodysplastic... Myelodysplastic... Non-Hodgkin Lym... Recurrent Hodgk... Refractory Acut... Refractory Myel... Small Lymphocyt... Therapy-Related...	Anti-Thymocyte ... Busulfan Clofarabine Cyclophosphamid... Filgrastim-sndz Fludarabine Melphalan Mycophenolate M... Rituximab Tacrolimus Total-Body Irra... Umbilical Cord ...	12 Years - 65 Years	M.D. Anderson Cancer Center
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting	NCT04128501	Acute Bilineal ... Acute Biphenoty... Acute Myeloid L... Mixed Phenotype... T Acute Lymphob... Therapy-Related...	Azacitidine Venetoclax	18 Years - 75 Years	M.D. Anderson Cancer Center
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation	NCT03683433	Acute Bilineal ... Acute Biphenoty... Chronic Myelomo... IDH2 Gene Mutat... Myelodysplastic... Recurrent Acute... Refractory Acut...	Azacitidine Enasidenib Mesy...	18 Years -	M.D. Anderson Cancer Center
Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia	NCT02397720	Acute Bilineal ... Acute Biphenoty... Acute Myeloid L... Chronic Myelomo... Myelodysplastic... Recurrent Acute... Refractory Acut... Secondary Acute... Therapy-Related...	Azacitidine Ipilimumab Laboratory Biom... Nivolumab	18 Years -	M.D. Anderson Cancer Center
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	NCT02728050	Acute Biphenoty... Acute Myeloid L... de Novo Myelody... Myelodysplastic... Myeloproliferat...	Cladribine Cytarabine Filgrastim Laboratory Biom... Quality-of-Life... Mitoxantrone Sorafenib	18 Years - 60 Years	University of Washington
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention	NCT01951885	Chronic Myeloge... Acute Lymphobla... Acute Myeloid L... Acute Biphenoty... Myelodysplastic... Myeloproliferat... Non-Hodgkin Lym... Hodgkins Diseas... Chronic Lymphoc... Multiple Myelom...	tacrolimus methotrexate Mycophenolate m... Methotrexate (l...	- 70 Years	Case Comprehensive Cancer Center
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation	NCT00990249	Leukemia Lymphoma Allogeneic Haem... Acute Lymphobla...	Busulfan Clofarabine Thymoglobulin Stem Cell Trans...	- 65 Years	M.D. Anderson Cancer Center
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention	NCT01951885	Chronic Myeloge... Acute Lymphobla... Acute Myeloid L... Acute Biphenoty... Myelodysplastic... Myeloproliferat... Non-Hodgkin Lym... Hodgkins Diseas... Chronic Lymphoc... Multiple Myelom...	tacrolimus methotrexate Mycophenolate m... Methotrexate (l...	- 70 Years	Case Comprehensive Cancer Center
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes	NCT01690520	Acute Biphenoty... Acute Lymphobla... Acute Myeloid L... Chronic Myeloge... Myelodysplastic...	Cyclophosphamid... Cyclosporine Ex Vivo-Expande... Fludarabine Pho... Mycophenolate M... Thiotepa Total-Body Irra... Umbilical Cord ...	6 Months - 65 Years	Nohla Therapeutics, Inc.
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes	NCT02044796	Acute Biphenoty... de Novo Myelody... Previously Trea... Recurrent Adult... Untreated Adult... Secondary Acute...	Cladribine Cytarabine Filgrastim Laboratory Biom... Mitoxantrone Hy...	18 Years -	Fred Hutchinson Cancer Center
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies	NCT05170828	Acute Leukemia Myelodysplastic... T-lymphoblastic... Acute Lymphocyt... Acute Myeloid L... Acute Biphenoty... Acute Undiffere...	Cyclophosphamid... Fludarabine Total Body Irra... Busulfan Mesna Sirolimus Mycophenolate M... Filgrastim Cyclophosphamid... Bone Marrow Tra...	18 Years - 70 Years	Ossium Health, Inc.
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia	NCT01804101	Acute Biphenoty... Acute Myeloid L... Myelodysplastic... Untreated Adult...	Laboratory Biom... Liposomal Cytar...	18 Years -	Fred Hutchinson Cancer Center
Lirilumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia	NCT02399917	Acute Biphenoty... Acute Myeloid L... Recurrent Acute... Refractory Acut...	Azacitidine Lirilumab	18 Years -	M.D. Anderson Cancer Center
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease	NCT00719888	Acute Biphenoty... Acute Lymphobla... Acute Myeloid L... Burkitt Lymphom... Chronic Lymphoc... Chronic Myeloge... Chronic Phase C... Follicular Lymp... Lymphoblastic L... Lymphoplasmacyt... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... Myelofibrosis Non-Hodgkin Lym... Plasma Cell Mye... Prolymphocytic ... Refractory Anem... Small Lymphocyt...	Cyclophosphamid... Cyclosporine Double-Unit Umb... Fludarabine Laboratory Biom... Mycophenolate M... Total-Body Irra... Umbilical Cord ... Thiotepa	6 Months - 45 Years	Fred Hutchinson Cancer Center
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms	NCT04797767	Acute Biphenoty... Acute Myeloid L... Mixed Phenotype... Myeloid Neoplas... Relapsed Acute ... Relapsed Acute ... Relapsed Mixed ... Relapsed Myeloi... Refractory Acut... Refractory Acut... Refractory Mixe... Refractory Myel... Recurrent Myelo...	Cladribine Cytarabine Mitoxantrone Recombinant Gra... Venetoclax	18 Years -	University of Washington
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia	NCT01804101	Acute Biphenoty... Acute Myeloid L... Myelodysplastic... Untreated Adult...	Laboratory Biom... Liposomal Cytar...	18 Years -	Fred Hutchinson Cancer Center
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting	NCT04128501	Acute Bilineal ... Acute Biphenoty... Acute Myeloid L... Mixed Phenotype... T Acute Lymphob... Therapy-Related...	Azacitidine Venetoclax	18 Years - 75 Years	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: